The role of nanotechnology in diabetes treatment: Current and future perspectives

International Journal of Nanotechnology

Volumn 8, Issue 1-2, 2011, Pages 53-65

  Samuel, Dennis ^a   Bharali, Dhruba ^a   Mousa, Shaker A ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Glucose sensors; Nanoparticles; Nanotechnology; Oral insulin

Indexed keywords

ARTIFICIAL ORGANS; DISEASES; GLUCOSE; GLUCOSE SENSORS; INSULIN; MEDICAL PROBLEMS; NANOPARTICLES; NANOTECHNOLOGY;

APPLICATIONS OF NANOTECHNOLOGIES; ARTIFICIAL PANCREAS; CHRONIC DISEASE; DIABETES RESEARCH; FOCAL POINTS; FUTURE PERSPECTIVES; GLUCOSE MONITORING SYSTEM;

DRUG DELIVERY;

EID: 78649694997     PISSN: 14757435     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJNT.2011.037170     Document Type: Article

References (54)

1. American Diabetes Association (2009) Diabetes Statistics, obtained through the internet: http://www.diabetes.org/diabetes-statistics.jsp [Accessed 8/15/2009].
2. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) 'Global prevalence of diabetes: estimates for the year 2000 and projections for 2030', Diabetes Care, Vol. 27, No. 5, pp.1047-1053.
3. American Diabetes Association (2009) Complications of Diabetes in the United States, obtained through the internet: http://www.diabetes.org [Accessed 8/15/2009].
4. Rodbard, H.W., Blonde, L., Braithwaite, S.S., Brett, E.M., Cobin, R.H., Handelsman, Y., Hellman, R., Jellinger, P.S., Jovanovic, L.G., Levy, P., Mechanick, J.I. and Zangeneh, F. (2007) 'American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus', Endocr. Pract., Vol. 13, Suppl. 1, pp.1-68.
5. Pickup, J.C., Zhi, Z.L., Khan, F., Saxl, T. and Birch, D.J. (2008) 'Nanomedicine and its potential in diabetes research and practice', Diabetes Metab. Res. Rev., Vol. 24, No. 8, pp.604-610.
6. Sahoo, S.K., Parveen, S. and Panda, J.J. (2007) 'The present and future of nanotechnology in human health care', Nanomedicine, Vol. 3, No. 1, pp.20-31.
7. Freitas Jr., R.A. (2005) 'What is nanomedicine?', Nanomedicine, Vol. 1, No. 1, pp.2-9.
8. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A. and Nathan, D.M. (2002) 'Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin', N. Engl. J. Med., Vol. 346, No. 6, pp.393-403.
9. American Diabetes Associaton (2009) 'Standards of medical care in diabetes-2009', Diabetes Care, Vol. 32, Suppl. 1, No. S13-61.
10. American Diabetes Association (2009) Diabetes Research Milestones, obtained through the internet: http://www.diabetes.org/diabetes-research/ diabetes-research-milestones.jsp [Accessed 8/15/2009].
11. Allan, F.N. (1972) 'Diabetes before and after insulin', Med. Hist., Vol. 16, No. 3, pp.266-273.
12. American Diabetes Association (2008) '2008 resource guide. Insulin delivery. Syringes..pumps..jet injectors..pens..infusers⋯they all do the same thing: deliver insulin through the outermost layer of skin and into fatty tissue so it can be used by the body', Diabetes Forecast, Vol. 61, No. 1, pp.RG17-29.
13. Brunton, S. (2008) 'Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens', Diabetes Technol. Ther., Vol. 10, No. 4, pp.247-256.
14. Korytkowski, M., Niskanen, L. and Asakura, T. (2005) 'FlexPen: addressing issues of confidence and convenience in insulin delivery', Clin. Ther., Vol. 27, Suppl. B, No. S89-S100.
15. American Diabetes Association (2009) Insulin Pumps, obtained through the internet: http://www.diabetes.org/type-1-diabetes/insulin-pumps.jsp [Accessed 8/17/2009].
16. Pickup, J., Mattock, M. and Kerry, S. (2002) 'Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials', BMJ, Vol. 324, No. 7339, pp.705.
17. Pickup, J.C. and Sutton, A.J. (2008) 'Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion', Diabet. Med., Vol. 25, No. 7, pp.765-774.
18. Nathan, D.M., Buse, J.B., Davidson, M.B., Ferrannini, E., Holman, R.R., Sherwin, R. and Zinman, B. (2009) 'Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes', Diabetes Care, Vol. 32, No. 1, pp.193-203.
19. UK Prospective Diabetes Study (UKPDS) Group (1998) 'Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)', Lancet, Vol. 352, No. 9131, pp.837-853.
20. Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N. and Shichiri, M. (1995) 'Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study', Diabetes Res. Clin. Pract., Vol. 28, No. 2, pp.103-117.
21. Korytkowski, M. (2002) 'When oral agents fail: practical barriers to starting insulin', Int. J. Obes. Relat. Metab. Disord., Vol. 26, Suppl. 3, pp.18-24.
22. Peppas, N.A. and Kavimandan, N.J. (2006) 'Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles', Eur. J. Pharm. Sci., Vol. 29, Nos. 3-4, pp.183-197.
23. Damge, C., Reis, C.P. and Maincent, P. (2008) 'Nanoparticle strategies for the oral delivery of insulin', Expert Opin. Drug. Deliv., Vol. 5, No. 1, pp.45-68.
24. Khafagy el, S., Morishita, M., Onuki, Y. and Takayama, K. (2007) 'Current challenges in non-invasive insulin delivery systems: a comparative review', Adv. Drug Delivery Rev., Vol. 59, No. 15, pp.1521-1546.
25. Woitiski, C.B., Carvalho, R.A., Ribeiro, A.J., Neufeld, R.J. and Veiga, F. (2008) 'Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation', BioDrugs, Vol. 22, No. 4, pp.223-237.
26. Venugopal, J., Prabhakaran, M.P., Low, S., Choon, A.T., Zhang, Y.Z., Deepika, G. and Ramakrishna, S. (2008) 'Nanotechnology for nanomedicine and delivery of drugs', Curr. Pharm. Des., Vol. 14, No. 22, pp.2184-2200.
27. Damge, C., Michel, C., Aprahamian, M. and Couvreur, P. (1988) 'New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier', Diabetes, Vol. 37, No. 2, pp.246-251.
28. Damge, C., Maincent, P. and Ubrich, N. (2007) 'Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats', J. Control Release, Vol. 117, No. 2, pp.163-170.
29. Pan, Y., Li, Y.J., Zhao, H.Y., Zheng, J.M., Xu, H., Wei, G., Hao, J.S. and Cui, F.D. (2002) 'Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo', Int. J. Pharm., Vol. 249, Nos. 1-2, pp.139-147.
30. Wong, T.W. (2009) 'Chitosan and its use in design of insulin delivery system', Recent. Pat. Drug Deliv. Formul., Vol. 3, No. 1, pp.8-25.
31. Bhumkar, D.R., Joshi, H.M., Sastry, M. and Pokharkar, V.B. (2007) 'Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin', Pharm. Res., Vol. 24, No. 8, pp.1415-1426.
32. Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R. and Ferreira, D. (2007) 'Alginate/chitosan nanoparticles are effective for oral insulin delivery', Pharm. Res., Vol. 24, No. 12, pp.2198-2206.
33. Elsayed, A., Remawi, M.A., Qinna, N., Farouk, A. and Badwan, A. (2009) 'Formulation and characterization of an oily-based system for oral delivery of insulin', Eur. J. Pharm. Biopharm, Vol. 73, No. 2, pp.269-279.
34. Yin, L., Ding, J., He, C., Cui, L., Tang, C. and Yin, C. (2009) 'Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery', Biomaterials, Vol. 30, No. 29, pp.5691-5700.
35. Verspohl, E.J. (2009) 'Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors', Pharmacol Ther., Vol. 124, No. 1, pp.113-138.
36. Oliver, N.S., Toumazou, C., Cass, A.E. and Johnston, D.G. (2009) 'Glucose sensors: a review of current and emerging technology', Diabet. Med., Vol. 26, No. 3, pp.197-210.
37. Brauker, J. (2009) 'Continuous glucose sensing: future technology developments', Diabetes Technol. Ther., Vol. 11, Suppl. 1, pp.25-36.
38. Klonoff, D.C. (2005) 'A review of continuous glucose monitoring technology', Diabetes Technol. Ther., Vol. 7, No. 5, pp.770-775.
39. Mastrototaro, J. and Lee, S. (2009) 'The integrated MiniMed Paradigm REAL-Time insulin pump and glucose monitoring system: implications for improved patient outcomes', Diabetes Technol. Ther., Vol. 11, Suppl 1, pp.37-43.
40. Saxl, T., Khan, F., Matthews, D.R., Zhi, Z.L., Rolinski, O., Ameer-Beg, S. and Pickup, J. (2009) 'Fluorescence lifetime spectroscopy and imaging of nano-engineered glucose sensor microcapsules based on glucose/galactose-binding protein', Biosens. Bioelectron., Vol. 24, No. 11, pp.3229-3234.
41. Rankin, J., Byrne, T. and McAdams, E. (2005) 'Non-mediated glucose biosensing using nanostructured TiO2', Stud. Health Technol. Inform., Vol. 117, pp.207-212.
42. Lu, J., Do, I., Drzal, L.T., Worden, R.M. and Lee, I. (2008) 'Nanometal-decorated exfoliated graphite nanoplatelet based glucose biosensors with high sensitivity and fast response', ACS Nano, Vol. 2, No. 9, pp.1825-32.
43. Ren, X., Chen, D., Meng, X., Tang, F., Du, A. and Zhang, L. (2009) 'Amperometric glucose biosensor based on a gold nanorods/cellulose acetate composite film as immobilization matrix', Colloids Surf., B, Vol. 72, No. 2, pp.188-192.
44. Gutzwiller, J.P., Drewe, J., Goke, B., Schmidt, H., Rohrer, B., Lareida, J. and Beglinger, C. (1999) 'Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2', Am. J. Physiol., Vol. 276, No. 5, Pt 2, pp.R1541-R1544.
45. Turton, M.D., O'Shea, D., Gunn, I., Beak, S.A., Edwards, C.M., Meeran, K., Choi, S.J., Taylor, G.M., Heath, M.M., Lambert, P.D., Wilding, J.P., Smith, D.M., Ghatei, M.A., Herbert, J. and Bloom, S.R. (1996) 'A role for glucagon-like peptide-1 in the central regulation of feeding', Nature, Vol. 379, No. 6560, pp.69-72. (Pubitemid 26008136)
46. Gallwitz, B. (2005) 'New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins', Rev. Diabet. Stud., Vol. 2, No. 2, pp.61-69.
47. Sandoval, D.A., Obici, S. and Seeley, R.J. (2009) 'Targeting the CNS to treat type 2 diabetes', Nat. Rev. Drug Discovery, Vol. 8, No. 5, pp.386-398.
48. Obici, S., Feng, Z., Morgan, K., Stein, D., Karkanias, G. and Rossetti, L. (2002) 'Central administration of oleic acid inhibits glucose production and food intake', Diabetes, Vol. 51, No. 2, pp.271-275.
49. Vergoni, A.V., Tosi, G., Tacchi, R., Vandelli, M.A., Bertolini, A. and Costantino, L. (2009) 'Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution', Nanomedicine, Vol. 5, No. 4, pp.369-377.
50. Banchellini, E., Macchiarini, S., Dini, V., Rizzo, L., Tedeschi, A., Scatena, A., Goretti, C., Campi, F., Romanelli, M. and Piaggesi, A. (2008) 'Use of nanotechnology-designed footsock in the management of preulcerative conditions in the diabetic foot: results of a single, blind randomized study', Int. J. Low. Extrem. Wounds, Vol. 7, No. 2, pp.82-87.
51. Naha, P.C., Kanchan, V., Manna, P.K. and Panda, A.K. (2008) 'Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles', J. Microencapsulation, Vol. 25, No. 4, pp.248-256.
52. Radwan, M.A. (2001) 'Enhancement of absorption of insulin-loaded polyisobutylcyanoacrylate nanospheres by sodium cholate after oral and subcutaneous administration in diabetic rats', Drug Dev. Ind. Pharm., Vol. 27, No. 9, pp.981-989.
53. Cui, F.D., Tao, A.J., Cun, D.M., Zhang, L.Q. and Shi, K. (2007) 'Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery', J. Pharm. Sci., Vol. 96, No. 2, pp.421-427.
54. Carino, G.P., Jacob, J.S. and Mathiowitz, E. (2000) 'Nanosphere based oral insulin delivery', J. Control Release, Vol. 65, Nos. 1-2, pp.261-269.